Choline Alfoscerate 400mg

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical, Daewoong Bio Inc.

Conditions

Alzheimer DiseaseVascular Cognitive Impairment

Phase 4

A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients

Chong Kun Dang PharmaceuticalVascular Cognitive Impairment

Start: 2021-09-30End: 2024-11-30Target: 418Updated: 2021-09-20

Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease

RecruitingNCT05383183

Daewoong Bio Inc.Alzheimer Disease

Start: 2022-01-20End: 2025-12-09Target: 630Updated: 2024-03-21